BRIDGEBIO ONCOLOGY THERAPEUTICS, INC.
Last · NASDAQ$8.98+0.08 (+0.90%)stale · yahoo · 99h ago
Market cap$719.96M80.2M sh
P/E · TTM-4.0fwd -3.7 · eps -2.27 · loss
Beta0.39vs S&P 500
Div yield—annual · TTM
52w range
$7.00$14.87
Volume117.6Ksession
Loading chart…
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.66
Est. revenue
0
Press & signals
- GlobeNewswire
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- GlobeNewswire
BBOT Reports Second Quarter 2026 Financial Results and Update on Corporate Progress